SFO
RLMD icon

Stokes Family Office’s Relmada Therapeutics RLMD Stock Holding History

Stokes Family Office’s Portfolio RLMD Stock Details RLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5,935
Closed -$220K – 292
2022
Q3 		$220K Buy
+5,935
New +$220K 0.03% 244